CVS Caremark settlement could save people billions on prescriptions
Allegations leveled against CVS Caremark accused the PBM of preferring more expensive versions of insulin in order to boost up its rebates, thus increasing prices for a lifesaving drug.
Read the full articleYou might also wanna read
CVS Caremark reaches settlement with FTC over insulin suit
Terms of the deal announced Tuesday are very similar to those the FTC reached with Express Scripts earlier this year, including requiring th
STAT+: FTC settles lawsuit with CVS Caremark over charges it manipulated insulin prices, impeded access
The FTC settled a lawsuit against CVS Caremark over allegations that the company artificially inflated the price of insulin and impeded acce
FTC settles lawsuit with Optum Rx, ending its campaign against the ‘big three’ PBMs
The agency had been suing the three largest pharmacy benefit managers over their alleged control of insulin prices. It reached agreements wi
The US FTC settles with a major pharmacy benefit manager over insulin rebating practices that inflated drug list prices (Caremark)
On 14 July 2026, the US Federal Trade Commission announced a proposed consent settlement with Caremark Rx and its affiliate Zinc Health Serv
FTC Secures Major Settlement with Caremark, Resolving Antitrust Case Against Second Drug Middleman
Settlement will drive down patients’ out-of-pocket costs, increase transparency and ensure community pharmacies are treated fairly The Feder
Minnesota wins $850K in settlement with CVS over false Medicaid claims for insulin pens
CVS Pharmacy agreed to pay $36.5 million total to settle a multi-state lawsuit.
Comments
Sign in to join the conversation.
No comments yet. Be the first.